Aims & Scope
npj Drug Discovery considers all aspects of drug design and discovery using experimental and computational techniques. The journal welcomes manuscripts involving any stage of drug development, including drug target identification, library screening, lead optimization, animal models and clinical trials.
The journal covers a broad range of topics including but not limited to:
- Computational drug design and molecular modeling
- Applications of machine learning in drug design and discovery
- Structure-based drug design
- Ligand-based drug design
- High-throughput screening and drug discovery platforms
- Bioactive compounds from natural sources
- Target identification and validation
- Biologics and therapeutic antibodies
- Peptide and protein drug design
- Drug binding thermodynamics and kinetics
- Pharmacokinetics and pharmacodynamics
- Drug repurposing and drug combination therapies
- Biomolecular interactions and drug mechanisms of action
- Preclinical and clinical development of drug candidates
The journal offers more choice to Nature Portfolio authors who are seeking a fully open-access and more inclusive platform for publishing their work. The journal is led by experts in drug discovery, medicinal chemistry, and pharmacology who collaborate to cultivate high-quality research. As part of the npj Series, this journal focuses on fostering global partnerships with the research community and other Springer Nature journals.
